Delivery Order SPE2DB20D3103-SPE2DB25FM6R2

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Rifampin 300 mg capsules. The contract is valued at $3,894.85 and has a completion date of September 25, 2023. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, one of the largest pharmaceutical distributors in the United States. The contract is for the delivery of Rifampin 300 mg capsules, a critical antibiotic medication, with a ceiling value of $2,148.60 and a completion date of September 25, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,563,956,698 units of Rifampin 300 mg capsules. The contract, valued at $1,203.66, has an ultimate completion date of March 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.92 firm fixed-price delivery order is for the supply of RIFAMPIN 150 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of 300 mg Rifampin capsules. The $3,447.37 firm fixed-price contract has a completion date of May 20, 2024 and is not associated with any set-aside designations. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300 MG CAPSULE 60S. The contract has a firm fixed price of $33,154.85 and a period of performance through January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $25,106.91 firm-fixed-price contract is for the supply of the drug rifampin 300 mg in 60-count capsules. The contract has a completion date of June 21, 2024 and was awarded on June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order valued at $27,852.48 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,381.11, is for the delivery of 60 capsules of 300 mg Rifampin, a medication used to treat certain bacterial infections. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,740.27, is for the delivery of 60 units of the medication Rifampin 300 mg capsules. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 19, 2023. This award is not associated with a set-aside program, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM6R2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,666.56, is a firm fixed-price delivery order for 4,567,237,200 units of the medication rifampin 300 mg capsules. The contract has a completion date of February 12, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/13/25, 10:22 AM